Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Windtree Therapeutics Inc
(NQ:
WINT
)
10.91
-0.23 (-2.06%)
Streaming Delayed Price
Updated: 11:46 AM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Windtree Therapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
(WINT) - Analyzing Windtree Therapeutics's Short Interest
August 01, 2024
Via
Benzinga
Why Windtree Therapeutics (WINT) Stock Is Volatile Today
July 29, 2024
Windtree Therapeutics shares are trading lower by 8.6% during Monday's session. The company announced it entered a $1M private placement.
Via
Benzinga
S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results
July 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
July 26, 2024
Via
Benzinga
Exposures
Fossil Fuels
Dow Surges 550 Points; Headline PCE Price Index Falls To 2.5%
July 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With Windtree Therapeutics Stock?
July 26, 2024
Windtree Therapeutics shares are racing higher Friday after the company requested the withdrawal of its Registration Statement previously filed with the SEC.
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Why Is Windtree Therapeutics (WINT) Stock Up 116% Today?
July 26, 2024
Windtree Therapeutics stock is up on Friday with heavy trading of WINT shares following an update on its clinical trials.
Via
InvestorPlace
(WINT) - Analyzing Windtree Therapeutics's Short Interest
April 23, 2024
Via
Benzinga
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 26, 2024
Via
Benzinga
Why Is DexCom (DXCM) Stock Down 38% Today?
July 26, 2024
DexCom stock is up on Friday as DXCM investors react to the company's latest earnings report and its lackluster 2024 guidance.
Via
InvestorPlace
Why Is BurgerFi International (BFI) Stock Up 71% Today?
July 26, 2024
BurgerFi International stock is up on Friday as investors in BFI react to it reaching a settlement agreement with Lion Point Capital, LP.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 26, 2024
Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday!
Via
InvestorPlace
Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
July 26, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 24, 2024
We're diving into the biggest pre-market stock movers that traders need to know about on Friday morning with all of the latest news!
Via
InvestorPlace
Why Windtree Therapeutics (WINT) Stock Is Getting Hammered
April 18, 2024
Windtree Therapeutics shares are trading lower by 30% during Thursday's session. The company announced it approved a 1-for-18 reverse stock split of its common stock.
Via
Benzinga
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 18, 2024
Via
Benzinga
WINT Stock Earnings: Windtree Therapeutics Beats EPS for Q4 2023
April 17, 2024
WINT stock results show that Windtree Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 02, 2024
Via
Benzinga
Windtree Therapeutics – This Biotech Inks License Deal For Lead Candidate
January 29, 2024
Craig Fraser, CEO of Windtree Therapeutics, Inc. (NASDAQ: WINT), was recently interviewed by Benzinga. Windtree is advancing late-stage interventions for cardiovascular disorders to treat patients in...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 25, 2024
Via
Benzinga
Windtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
January 25, 2024
Windtree Therapeutics (NASDAQ: WINT) announced an agreement with affiliates of biopharma investor Deerfield Management Company to fully retire a $15 million contingent liability associated with...
Via
Benzinga
Week in Review: Lee’s Pharma Signs $138 Million Agreement For China Rights To Heart Failure Therapy
January 20, 2024
Lee’s Pharma acquired China rights to a heart failure therapy from Windtree Therapeutics. Meanwhile, AstraZeneca signed an investment cooperation agreement with the Taizhou National Medical High-tech...
Via
Talk Markets
12 Health Care Stocks Moving In Friday's After-Market Session
January 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 17, 2024
Via
Benzinga
Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China
January 17, 2024
Greater China holds a significant, if not the world’s largest, acute heart failure patient population.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 17, 2024
Via
Benzinga
Windtree Therapeutics Announces Reduction In Arrhythmias In A New Study With Istaroxime And A Pure SERCA2a Activator
January 03, 2024
Arrhythmias are irregular heartbeats that can impact the pumping function of the heart. Patients with heart failure and cardiomyopathy are at risk for arrhythmias. Arrhythmias in these patients can be...
Via
Benzinga
Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected mid-2024
December 18, 2023
Windtree Therapeutics, Inc. (NASDAQ: WINT) has recently enrolled the first subject in its phase 2 SEISMiC Extension Study to evaluate istaroxime in the treatment of early cardiogenic shock.
Via
Benzinga
Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
October 10, 2023
Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.